Gilead Sciences, Inc. (GILD)
136.31
+6.70
(+5.17%)
USD |
NASDAQ |
Jul 07, 16:00
136.31
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Max Drawdown (5Y) : 26.58% for June 30, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.58% |
| May 31, 2026 | 26.58% |
| April 30, 2026 | 26.58% |
| March 31, 2026 | 26.58% |
| February 28, 2026 | 28.82% |
| January 31, 2026 | 29.81% |
| December 31, 2025 | 31.41% |
| November 30, 2025 | 35.24% |
| October 31, 2025 | 37.27% |
| September 30, 2025 | 38.10% |
| August 31, 2025 | 38.10% |
| July 31, 2025 | 38.10% |
| June 30, 2025 | 38.10% |
| May 31, 2025 | 38.10% |
| April 30, 2025 | 38.10% |
| March 31, 2025 | 38.10% |
| February 28, 2025 | 38.10% |
| January 31, 2025 | 38.70% |
| December 31, 2024 | 41.71% |
| November 30, 2024 | 41.71% |
| October 31, 2024 | 41.71% |
| September 30, 2024 | 43.12% |
| August 31, 2024 | 43.18% |
| July 31, 2024 | 43.18% |
| June 30, 2024 | 43.18% |
| Date | Value |
|---|---|
| May 31, 2024 | 43.18% |
| April 30, 2024 | 43.67% |
| March 31, 2024 | 44.02% |
| February 29, 2024 | 44.02% |
| January 31, 2024 | 44.02% |
| December 31, 2023 | 44.02% |
| November 30, 2023 | 45.75% |
| October 31, 2023 | 45.75% |
| September 30, 2023 | 45.75% |
| August 31, 2023 | 45.75% |
| July 31, 2023 | 45.75% |
| June 30, 2023 | 45.75% |
| May 31, 2023 | 45.75% |
| April 30, 2023 | 45.75% |
| March 31, 2023 | 45.75% |
| February 28, 2023 | 45.75% |
| January 31, 2023 | 45.75% |
| December 31, 2022 | 45.75% |
| November 30, 2022 | 45.75% |
| October 31, 2022 | 45.75% |
| September 30, 2022 | 45.75% |
| August 31, 2022 | 45.75% |
| July 31, 2022 | 45.75% |
| June 30, 2022 | 45.75% |
| May 31, 2022 | 45.75% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Biogen, Inc. | 72.66% |
| Amgen, Inc. | 24.86% |
| Johnson & Johnson | 18.44% |
| Eli Lilly & Co. | 34.47% |